Chemomab Therapeutics Ltd - ADR (CMMB:NASDAQ)

$1.88 0.05 (2.73%)

watchlist-icon
search-icon
Profile Icon

This Week's Average Sentiment Analysis Score (0 to 100): 80

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]

Change Analysis Timeline Daily Weekly Monthly subspinner

Analysed Chemomab Therapeutics Ltd - ADR (CMMB:NASDAQ) News Sources

Chemomab Therapeutics to Participate in Oppenheimer 36th Annual Healthcare Life Sciences Conference

The Globe and Mail

CMMB stock
CMMB stock price
CMMB stock price today
CMMB stock prediction
CMMB earnings date
CMMB news
CMMB price
CMMB share
CMMB share price
CMMB shares
CMMB ceo
CMMB premarket
$CMMB
CMMB ticker
CMMB after hours
CMMB stock
CMMB stock price
CMMB stock price today
CMMB stock prediction
CMMB earnings date
CMMB news
CMMB price
CMMB share
CMMB share price
CMMB shares
CMMB ceo
CMMB premarket
$CMMB
CMMB ticker
CMMB after hours

Chemomab Therapeutics Ltd - ADR (CMMB:NASDAQ) FAQs

toggle

What is the current price of Chemomab Therapeutics Ltd - ADR (CMMB:NASDAQ)?

The current price of Chemomab Therapeutics Ltd - ADR (CMMB:NASDAQ) is $1.88.


toggle

Chemomab Therapeutics Ltd - ADR (CMMB:NASDAQ) absolute price change since previous trading day?

The absolute price change of Chemomab Therapeutics Ltd - ADR (CMMB:NASDAQ) since the previous trading day is $0.05.


toggle

Chemomab Therapeutics Ltd - ADR (CMMB:NASDAQ) percentage price change since previous trading day?

The percentage price change of Chemomab Therapeutics Ltd - ADR (CMMB:NASDAQ) since the previous trading day is 2.73%.


toggle

What is This Week's average sentiment score for Chemomab Therapeutics Ltd - ADR (CMMB:NASDAQ)?

This Week's average sentiment score for Chemomab Therapeutics Ltd - ADR (CMMB:NASDAQ) is 80 out of 100.


toggle

What is This Week's average sentiment for Chemomab Therapeutics Ltd - ADR (CMMB:NASDAQ)?

This Week's sentiment for Chemomab Therapeutics Ltd - ADR (CMMB:NASDAQ) is .


Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.